Advancement in Understanding the Concept of Epithelial to Mesenchymal
Transition in Pancreatic β-Cells: Implication in Diabetes

Meenal      Francis; Akshaya      Ashok; Ashwini      Ashwathnarayan; Shreetama      Banerjee; Jyothi      Prasanna; Anujith      Kumar
doi:10.2174/1573399818666220519143414
Abstract

Distinct molecular processes are engaged during histogenesis, and Epithelial to Mesenchymal Transition (EMT) is one of the key evolutionarily conserved processes that facilitates organ development. Molecular pathways governing EMT are embedded within developmental programs and operate in cells of different tissues. Among varied cell types, EMT in pancreatic β-cells is of greater interest as the existence of EMT in these cells is highly debated. Although in vitro generation of human islet-derived mesenchymal progenitor cells has been proven beyond doubt, the existence of EMT in pancreatic β-cells in vivo remains enigmatic. Understanding the in-depth process of EMT in in vivo human β-cells is challenged by the limitations of lineage-tracing studies, which are otherwise feasible in mice. Exploring EMT of β-cells would greatly facilitate the generation of clinically relevant β-cells either by enhancing long-term in vitro culture of endogenous islets or by differentiation of pluripotent stem cells to mature β-cells. This review is an update on the recent progress in understanding the EMT process of β-cells and how the investigations have helped to resolve the mystery of the existence of EMT in pancreatic β-cells.
Keywords: Epithelial, Mesenchymal transition, EMT, Islets, Pancreatic β-cells, Diabetes, dedifferentiation
[1]
Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci  2020; 21(17): 6275.
 [http://dx.doi.org/10.3390/ijms21176275] [PMID:  32872570]

[2]
Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne)  2013; 4: 37.
 [http://dx.doi.org/10.3389/fendo.2013.00037] [PMID:  23542897]

[3]
Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomed Pharmacother  2018; 107: 306-28.
 [http://dx.doi.org/10.1016/j.biopha.2018.07.157] [PMID:  30098549]

[4]
Sumi S, Gu Y, Hiura A, Inoue K. Stem cells and regenerative medicine for diabetes mellitus. Pancreas  2004; 29(3): e85-9.
 [http://dx.doi.org/10.1097/00006676-200410000-00017] [PMID:  15367898]

[5]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care  2013; 36 (Suppl. 1): S67-74.

[6]
Farney AC, Sutherland DE, Opara EC. Evolution of islet transplantation for the last 30 years. Pancreas  2016; 45(1): 8-20.
 [http://dx.doi.org/10.1097/MPA.0000000000000391] [PMID:  26658037]

[7]
Sasaki H, Saisho Y, Inaishi J, Itoh H. Revisiting regulators of human β-cell mass to achieve β-cell-centric approach toward type 2 diabetes. J Endocr Soc  2021; 5(10): bvab128.

[8]
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-cell deficit and increased β-cell apoptosis in humans with  type 2 diabetes Diabetes  2003; 52(1): 102-10.
 [http://dx.doi.org/10.2337/diabetes.52.1.102] [PMID:  12502499]

[9]
Jonas JC, Bensellam M, Duprez J, Elouil H, Guiot Y, Pascal SMA. Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes Metab  2009; 11 (Suppl. 4): 65-81.
 [http://dx.doi.org/10.1111/j.1463-1326.2009.01112.x] [PMID:  19817790]

[10]
Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell  2012; 150(6): 1223-34.
 [http://dx.doi.org/10.1016/j.cell.2012.07.029] [PMID:  22980982]

[11]
Cinti F, Bouchi R, Kim-Muller JY, et al. Evidence of beta-cell dedifferentiation in human type 2 diabetes. J Clin Endocrinol Metab  2016; 101(3): 1044-54.
 [http://dx.doi.org/10.1210/jc.2015-2860] [PMID:  26713822]

[12]
Sun T, Han X. Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes. Semin Cell Dev Biol  2020; 103: 76-82.
 [http://dx.doi.org/10.1016/j.semcdb.2019.12.002] [PMID:  31831356]

[13]
Infeld DA, O’Shea JG. Diabetic retinopathy. Postgrad Med J  1998; 74(869): 129-33.
 [http://dx.doi.org/10.1136/pgmj.74.869.129] [PMID:  9640436]

[14]
Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke: Epidemiology and possible mechanisms. Diabetes Care  2007; 30(12): 3131-40.
 [http://dx.doi.org/10.2337/dc06-1537] [PMID:  17848611]

[15]
Huo X, Gao L, Guo L, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: A cross-sectional study. Lancet Diabetes Endocrinol  2016; 4(2): 115-24.
 [http://dx.doi.org/10.1016/S2213-8587(15)00508-2] [PMID:  26704379]

[16]
Mariam TG, Alemayehu A, Tesfaye E, et al. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients who attend the diabetic follow-up clinic at the university of Gondar referral hospital, northwest Ethiopia, 2016: Institutional-based cross-sectional study. J Diabetes Res  2017; 2017: 2879249.
 [http://dx.doi.org/10.1155/2017/2879249] [PMID:  28791310]

[17]
Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med  2000; 343(4): 230-8.
 [http://dx.doi.org/10.1056/NEJM200007273430401] [PMID:  10911004]

[18]
Sutherland DER, Gruessner R, Kandswamy R, Humar A, Hering B, Gruessner A. Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach. Transplant Proc  2004; 36(6): 1697-9.
 [http://dx.doi.org/10.1016/j.transproceed.2004.06.069] [PMID:  15350456]

[19]
Bhonde RR, Sheshadri P, Sharma S, Kumar A. Making surrogate β-cells from mesenchymal stromal cells: Perspectives and future endeav-ors. Int J Biochem Cell Biol  2014; 46: 90-102.
 [http://dx.doi.org/10.1016/j.biocel.2013.11.006] [PMID:  24275096]

[20]
Kaiser N, Corcos AP, Tur-Sinai A, Ariav Y, Cerasi E. Monolayer culture of adult rat pancreatic islets on extracellular matrix: Long term maintenance of differentiated B-cell function. Endocrinology  1988; 123(2): 834-40.
 [http://dx.doi.org/10.1210/endo-123-2-834] [PMID:  2456205]

[21]
Hayek A, Lopez AD, Beattie GM. Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol  1989; 25(2): 146-50.
 [http://dx.doi.org/10.1007/BF02626171] [PMID:  2646271]

[22]
Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS. Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes  1995; 44(12): 1458-60.
 [http://dx.doi.org/10.2337/diab.44.12.1458] [PMID:  7589854]

[23]
Cornelius JG, Tchernev V, Kao KJ, Peck AB. In vitro-generation of islets in long-term cultures of pluripotent stem cells from adult mouse pancreas. Horm Metab Res  1997; 29(6): 271-7.
 [http://dx.doi.org/10.1055/s-2007-979036] [PMID:  9230348]

[24]
Beattie GM, Lappi DA, Baird A, Hayek A. Selective elimination of fibroblasts from pancreatic islet monolayers by basic fibroblast growth factor-saporin mitotoxin. Diabetes  1990; 39(8): 1002-5.
 [http://dx.doi.org/10.2337/diab.39.8.1002] [PMID:  2165003]

[25]
Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science  2004; 306(5705): 2261-4.
 [http://dx.doi.org/10.1126/science.1101968] [PMID:  15564314]

[26]
Davani B, Ikonomou L, Raaka BM, et al. Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells  2007; 25(12): 3215-22.
 [http://dx.doi.org/10.1634/stemcells.2007-0323] [PMID:  17901402]

[27]
Davani B, Ariely S, Ikonomou L, Oron Y, Gershengorn MC. Human islet-derived precursor cells can cycle between epithelial clusters and mesenchymal phenotypes. J Cell Mol Med  2009; 13(8B): 2570-81.
 [http://dx.doi.org/10.1111/j.1582-4934.2008.00570.x] [PMID:  19175683]

[28]
Moreno-Amador JL, Téllez N, Marin S, et al. Epithelial to mesenchymal transition in human endocrine islet cells. PLoS One  2018; 13(1): e0191104.
 [http://dx.doi.org/10.1371/journal.pone.0191104] [PMID:  29360826]

[29]
Atouf F, Park CH, Pechhold K, Ta M, Choi Y, Lumelsky NL. No evidence for mouse pancreatic beta-cell epithelial-mesenchymal transi-tion in vitro. Diabetes  2007; 56(3): 699-702.
 [http://dx.doi.org/10.2337/db06-1446] [PMID:  17327438]

[30]
Chen J, Han Q, Pei D. EMT and MET as paradigms for cell fate switching. J Mol Cell Biol  2012; 4(2): 66-9.
 [http://dx.doi.org/10.1093/jmcb/mjr045] [PMID:  22140271]

[31]
Nakaya Y, Sheng G. EMT in developmental morphogenesis. Cancer Lett  2013; 341(1): 9-15.
 [http://dx.doi.org/10.1016/j.canlet.2013.02.037] [PMID:  23462225]

[32]
Lai X, Li Q, Wu F, et al. Epithelial-mesenchymal transition and metabolic switching in cancer: Lessons from somatic cell reprogramming. Front Cell Dev Biol  2020; 8: 760.
 [http://dx.doi.org/10.3389/fcell.2020.00760] [PMID:  32850862]

[33]
López-Novoa JM, Nieto MA. Inflammation and EMT: An alliance towards organ fibrosis and cancer progression. EMBO Mol Med  2009; 1(6-7): 303-14.
 [http://dx.doi.org/10.1002/emmm.200900043] [PMID:  20049734]

[34]
Lim J, Thiery JP. Epithelial-mesenchymal transitions: insights from development. Development  2012; 139(19): 3471-86.
 [http://dx.doi.org/10.1242/dev.071209] [PMID:  22949611]

[35]
Amack JD. Cellular dynamics of EMT: Lessons from live in vivo imaging of embryonic development. Cell Commun Signal  2021; 19(1): 79.
 [http://dx.doi.org/10.1186/s12964-021-00761-8] [PMID:  34294089]

[36]
Scheibner K, Schirge S, Burtscher I, et al. Epithelial cell plasticity drives endoderm formation during gastrulation. Nat Cell Biol  2021; 23(7): 692-703.
 [http://dx.doi.org/10.1038/s41556-021-00694-x] [PMID:  34168324]

[37]
Davies JA, Garrod DR. Molecular aspects of the epithelial phenotype. BioEssays  1997; 19(8): 699-704.
 [http://dx.doi.org/10.1002/bies.950190810] [PMID:  9264252]

[38]
Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest  2009; 119(6): 1420-8.
 [http://dx.doi.org/10.1172/JCI39104] [PMID:  19487818]

[39]
Bilder D, Schober M, Perrimon N. Integrated activity of PDZ protein complexes regulates epithelial polarity. Nat Cell Biol  2003; 5(1): 53-8.
 [http://dx.doi.org/10.1038/ncb897] [PMID:  12510194]

[40]
Hurd TW, Gao L, Roh MH, Macara IG, Margolis B. Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nat Cell Biol  2003; 5(2): 137-42.
 [http://dx.doi.org/10.1038/ncb923] [PMID:  12545177]

[41]
Tanentzapf G, Tepass U. Interactions between the crumbs, lethal giant larvae and bazooka pathways in epithelial polarization. Nat Cell Biol  2003; 5(1): 46-52.
 [http://dx.doi.org/10.1038/ncb896] [PMID:  12510193]

[42]
Whiteman EL, Liu CJ, Fearon ER, Margolis B. The transcription factor snail represses Crumbs3 expression and disrupts apico-basal po-larity complexes. Oncogene  2008; 27(27): 3875-9.
 [http://dx.doi.org/10.1038/onc.2008.9] [PMID:  18246119]

[43]
Viloria-Petit AM, Wrana JL. The TGFbeta-Par6 polarity pathway: Linking the Par complex to EMT and breast cancer progression. Cell Cycle  2010; 9(4): 623-4.
 [http://dx.doi.org/10.4161/cc.9.4.10779] [PMID:  20107326]

[44]
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol  2014; 15(3): 178-96.
 [http://dx.doi.org/10.1038/nrm3758] [PMID:  24556840]

[45]
Lee K, Nelson CM. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int Rev Cell Mol Biol  2012; 294: 171-221.
 [http://dx.doi.org/10.1016/B978-0-12-394305-7.00004-5] [PMID:  22364874]

[46]
Jung AR, Jung C-H, Noh JK, Lee YC, Eun YG. Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma. Sci Rep  2020; 10(1): 3652.
 [http://dx.doi.org/10.1038/s41598-020-60707-x] [PMID:  32107458]

[47]
Wang H, Wang H-S, Zhou B-H, et al. Epithelial-Mesenchymal Transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer. PLoS One  2013; 8(2): e56664.
 [http://dx.doi.org/10.1371/journal.pone.0056664] [PMID:  23431386]

[48]
Skrypek N, Goossens S, De Smedt E, Vandamme N, Berx G. Epithelial-to-mesenchymal transition: Epigenetic reprogramming driving cellular plasticity. Trends Genet  2017; 33(12): 943-59.
 [http://dx.doi.org/10.1016/j.tig.2017.08.004] [PMID:  28919019]

[49]
Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer  2016; 15(1): 18.
 [http://dx.doi.org/10.1186/s12943-016-0502-x] [PMID:  26905733]

[50]
Dong B, Qiu Z, Wu Y. Tackle epithelial-mesenchymal transition with epigenetic drugs in cancer. Front Pharmacol  2020; 11: 596239.
 [http://dx.doi.org/10.3389/fphar.2020.596239] [PMID:  33343366]

[51]
Title AC, Hong S-J, Pires ND, et al. Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion. Nat Commun  2018; 9(1): 4671.
 [http://dx.doi.org/10.1038/s41467-018-07130-z] [PMID:  30405106]

[52]
Grieco GE, Brusco N, Licata G, et al. The landscape of microRNAs in βcell: Between phenotype maintenance and protection. Int J Mol Sci  2021; 22(2): 803.
 [http://dx.doi.org/10.3390/ijms22020803] [PMID:  33466949]

[53]
Montgomery AM, Yebra M. The epithelial-to-mesenchymal transition of human pancreatic β-cells: Inductive mechanisms and implications for the cell-based therapy of type I diabetes. Curr Diabetes Rev  2011; 7(5): 346-55.
 [http://dx.doi.org/10.2174/157339911797415639] [PMID:  21916835]

[54]
Chen C-M, Juan S-H, Pai M-H, Chou HC. Hyperglycemia induces epithelial-mesenchymal transition in the lungs of experimental diabetes mellitus. Acta Histochem  2018; 120(6): 525-33.
 [http://dx.doi.org/10.1016/j.acthis.2018.06.004] [PMID:  29934127]

[55]
Joglekar MV, Hardikar AA. Epithelial-to-mesenchymal transition in pancreatic islet beta cells. Cell Cycle  2010; 9(20): 4077-9.
 [http://dx.doi.org/10.4161/cc.9.20.13590] [PMID:  20948307]

[56]
Talchai C, Xuan S, Kitamura T, DePinho RA, Accili D. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet  2012; 44(4): 406-12.
 [http://dx.doi.org/10.1038/ng.2215]

[57]
Roefs MM, Carlotti F, Jones K, et al. Increased vimentin in human α- and β-cells in type 2 diabetes. J Endocrinol  2017; 233(3): 217-27.
 [http://dx.doi.org/10.1530/JOE-16-0588] [PMID:  28348116]

[58]
Efrat S. Beta-cell dedifferentiation in type 2 diabetes: Concise review. Stem Cells  2019; 37(10): 1267-72.
 [http://dx.doi.org/10.1002/stem.3059] [PMID:  31298804]

[59]
Khin PP, Lee JH, Jun HS. A brief review of the mechanisms of β-cell dedifferentiation in type 2 diabetes. Nutrients  2021; 13(5): 1593.
 [http://dx.doi.org/10.3390/nu13051593] [PMID:  34068827]

[60]
Puri S, Hebrok M. Cellular plasticity within the pancreas--lessons learned from development. Dev Cell  2010; 18(3): 342-56.
 [http://dx.doi.org/10.1016/j.devcel.2010.02.005] [PMID:  20230744]

[61]
McKnight KD, Wang P, Kim SK. Deconstructing pancreas development to reconstruct human islets from pluripotent stem cells. Cell Stem Cell  2010; 6(4): 300-8.
 [http://dx.doi.org/10.1016/j.stem.2010.03.003] [PMID:  20362535]

[62]
Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development  1996; 122(3): 983-95.
 [http://dx.doi.org/10.1242/dev.122.3.983] [PMID:  8631275]

[63]
Pictet RL, Clark WR, Williams RH, Rutter WJ. An ultrastructural analysis of the developing embryonic pancreas. Dev Biol  1972; 29(4): 436-67.
 [http://dx.doi.org/10.1016/0012-1606(72)90083-8] [PMID:  4570759]

[64]
Slack JM. Developmental biology of the pancreas. Development  1995; 121(6): 1569-80.
 [http://dx.doi.org/10.1242/dev.121.6.1569] [PMID:  7600975]

[65]
Kim SK, MacDonald RJ. Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev  2002; 12(5): 540-7.
 [http://dx.doi.org/10.1016/S0959-437X(02)00338-6] [PMID:  12200159]

[66]
Bilyk O, Coatham M, Jewer M, Postovit LM. Epithelial-to-mesenchymal transition in the female reproductive tract: From normal function-ing to disease pathology. Front Oncol  2017; 7: 145.
 [http://dx.doi.org/10.3389/fonc.2017.00145] [PMID:  28725636]

[67]
Hashimoto K, Nakatsuji N. Formation of the primitive streak and mesoderm cells in mouse embryos-detailed scanning electron micro-scopical study. Dev Growth Differ  1989; 31(3): 209-18.
 [http://dx.doi.org/10.1111/j.1440-169X.1989.00209.x]

[68]
Ferrer-Vaquer A, Viotti M, Hadjantonakis AK. Transitions between epithelial and mesenchymal states and the morphogenesis of the early mouse embryo. Cell Adhes Migr  2010; 4(3): 447-57.
 [http://dx.doi.org/10.4161/cam.4.3.10771] [PMID:  20200481]

[69]
Nakaya Y, Sheng G. Epithelial to mesenchymal transition during gastrulation: An embryological view. Dev Growth Differ  2008; 50(9): 755-66.
 [http://dx.doi.org/10.1111/j.1440-169X.2008.01070.x] [PMID:  19046163]

[70]
Nieto MA, Sargent MG, Wilkinson DG, Cooke J. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science  1994; 264(5160): 835-9.
 [http://dx.doi.org/10.1126/science.7513443] [PMID:  7513443]

[71]
Sun X, Meyers EN, Lewandoski M, Martin GR. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev  1999; 13(14): 1834-46.
 [http://dx.doi.org/10.1101/gad.13.14.1834] [PMID:  10421635]

[72]
Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol  2001; 21(23): 8184-8.
 [http://dx.doi.org/10.1128/MCB.21.23.8184-8188.2001] [PMID:  11689706]

[73]
Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell  2009; 139(5): 871-90.
 [http://dx.doi.org/10.1016/j.cell.2009.11.007] [PMID:  19945376]

[74]
Papaioannou VE. The T-box gene family: Emerging roles in development, stem cells and cancer. Development  2014; 141(20): 3819-33.
 [http://dx.doi.org/10.1242/dev.104471] [PMID:  25294936]

[75]
Ramkumar N, Omelchenko T, Silva-Gagliardi NF, McGlade CJ, Wijnholds J, Anderson KV. Crumbs2 promotes cell ingression during the epithelial-to-mesenchymal transition at gastrulation. Nat Cell Biol  2016; 18(12): 1281-91.
 [http://dx.doi.org/10.1038/ncb3442] [PMID:  27870829]

[76]
Bazzi H, Soroka E, Alcorn HL, Anderson KV. STRIP1, a core component of STRIPAK complexes, is essential for normal mesoderm migration in the mouse embryo. Proc Natl Acad Sci USA  2017; 114(51): E10928-36.
 [http://dx.doi.org/10.1073/pnas.1713535114] [PMID:  29203676]

[77]
Hebrok M, Kim SK, Melton DA. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev  1998; 12(11): 1705-13.
 [http://dx.doi.org/10.1101/gad.12.11.1705] [PMID:  9620856]

[78]
Johansson KA, Grapin-Botton A. Development and diseases of the pancreas. Clin Genet  2002; 62(1): 14-23.
 [http://dx.doi.org/10.1034/j.1399-0004.2002.620102.x] [PMID:  12123481]

[79]
Pan FC, Wright C. Pancreas organogenesis: From bud to plexus to gland. Dev Dyn  2011; 240(3): 530-65.
 [http://dx.doi.org/10.1002/dvdy.22584] [PMID:  21337462]

[80]
Deutsch G, Jung J, Zheng M, Lóra J. Zaret KS. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development  2001; 128(6): 871-81.
 [http://dx.doi.org/10.1242/dev.128.6.871] [PMID:  11222142]

[81]
Jensen J, Heller RS, Funder-Nielsen T, et al. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: A role for the notch pathway in repression of premature differentiation. Diabetes  2000; 49(2): 163-76.
 [http://dx.doi.org/10.2337/diabetes.49.2.163] [PMID:  10868931]

[82]
Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development  2002; 129(10): 2447-57.
 [http://dx.doi.org/10.1242/dev.129.10.2447] [PMID:  11973276]

[83]
Gu G, Brown JR, Melton DA. Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis. Mech Dev  2003; 120(1): 35-43.
 [http://dx.doi.org/10.1016/S0925-4773(02)00330-1] [PMID:  12490294]

[84]
Rukstalis JM, Habener JF. Snail2, a mediator of epithelial-mesenchymal transitions, expressed in progenitor cells of the developing endo-crine pancreas. Gene Expr Patterns  2007; 7(4): 471-9.
 [http://dx.doi.org/10.1016/j.modgep.2006.11.001] [PMID:  17185046]

[85]
Cole L, Anderson M, Antin PB, Limesand SW. One process for pancreatic β-cell coalescence into islets involves an epithelial-mesenchymal transition. J Endocrinol  2009; 203(1): 19-31.
 [http://dx.doi.org/10.1677/JOE-09-0072] [PMID:  19608613]

[86]
Gouzi M, Kim YH, Katsumoto K, Johansson K, Grapin-Botton A. Neurogenin3 initiates stepwise delamination of differentiating endocrine cells during pancreas development. Dev Dyn  2011; 240(3): 589-604.
 [http://dx.doi.org/10.1002/dvdy.22544] [PMID:  21287656]

[87]
Chiang MK, Melton DA. Single-cell transcript analysis of pancreas development. Dev Cell  2003; 4(3): 383-93.
 [http://dx.doi.org/10.1016/S1534-5807(03)00035-2] [PMID:  12636919]

[88]
Parnaud G, Lavallard V, Bedat B, et al. Cadherin engagement improves insulin secretion of single human β-cells. Diabetes  2015; 64(3): 887-96.
 [http://dx.doi.org/10.2337/db14-0257] [PMID:  25277393]

[89]
Avrahami D, Wang YJ, Schug J, et al. Single-cell transcriptomics of human islet ontogeny defines the molecular basis of β-cell dedifferentiation in T2D. Mol Metab  2020; 42: 101057.
 [http://dx.doi.org/10.1016/j.molmet.2020.101057] [PMID:  32739450]

[90]
Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med  2000; 6(3): 278-82.
 [http://dx.doi.org/10.1038/73128] [PMID:  10700229]

[91]
Zulewski H, Abraham EJ, Gerlach MJ, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes  2001; 50(3): 521-33.
 [http://dx.doi.org/10.2337/diabetes.50.3.521] [PMID:  11246871]

[92]
Morton RA, Geras-Raaka E, Wilson LM, Raaka BM, Gershengorn MC. Endocrine precursor cells from mouse islets are not generated by epithelial-to-mesenchymal transition of mature beta cells. Mol Cell Endocrinol  2007; 270(1-2): 87-93.
 [http://dx.doi.org/10.1016/j.mce.2007.02.005] [PMID:  17363142]

[93]
Weinberg N, Ouziel-Yahalom L, Knoller S, Efrat S, Dor Y. Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic beta-cells. Diabetes  2007; 56(5): 1299-304.
 [http://dx.doi.org/10.2337/db06-1654] [PMID:  17303800]

[94]
Chase LG, Ulloa-Montoya F, Kidder BL, Verfaillie CM. Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal tran-sition from Pdx-1 or insulin-positive cells. Diabetes  2007; 56(1): 3-7.
 [http://dx.doi.org/10.2337/db06-1165] [PMID:  17110468]

[95]
Guy LG, Kothary R, Wall L. Position effects in mice carrying a lacZ transgene in cis with the beta-globin LCR can be explained by a graded model. Nucleic Acids Res  1997; 25(21): 4400-7.
 [http://dx.doi.org/10.1093/nar/25.21.4400] [PMID:  9336475]

[96]
Jolly MK, Boareto M, Huang B, et al. Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front Oncol  2015; 5: 155.
 [http://dx.doi.org/10.3389/fonc.2015.00155] [PMID:  26258068]

[97]
Nimkulrat SD, Bernstein MN, Ni Z, Brown J, Kendziorski C, Blum B. The Anna Karenina model of β-cell maturation in development and their dedifferentiation in type 1 and type 2 diabetes. Diabetes  2021; 70(9): 2058-66.
 [http://dx.doi.org/10.2337/db21-0211] [PMID:  34417264]

[98]
Xiao X, Fischbach S, Zhang T, et al. SMAD3/Stat3 signaling mediates β-cell epithelial-mesenchymal transition in chronic pancreatitis–related diabetes. Diabetes  2017; 66(10): 2646-58.
 [http://dx.doi.org/10.2337/db17-0537] [PMID:  28775125]

[99]
Heinis M, Simon MT, Ilc K, et al. Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha. Diabetes  2010; 59(3): 662-9.
 [http://dx.doi.org/10.2337/db09-0891] [PMID:  20009089]

[100]
Liu N, Cai X, Liu T, et al. Hypoxia-inducible factor-1α mediates the expression of mature β cell-disallowed genes in hypoxia-induced β cell dedifferentiation. Biochem Biophys Res Commun  2020; 523(2): 382-8.
 [http://dx.doi.org/10.1016/j.bbrc.2019.12.063] [PMID:  31866014]

[101]
Pascal SM, Guiot Y, Pelengaris S, Khan M, Jonas JC. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets. Am J Physiol Endocrinol Metab  2008; 295(1): E92-E102.
 [http://dx.doi.org/10.1152/ajpendo.90235.2008] [PMID:  18413670]

[102]
Bensellam M, Jonas J-C, Laybutt DR. Mechanisms of β-cell dedifferentiation in diabetes: Recent findings and future research directions. J Endocrinol  2018; 236(2): R109-43.
 [http://dx.doi.org/10.1530/JOE-17-0516] [PMID:  29203573]

[103]
Ježek P, Jabůrek M, Plecitá-Hlavatá L. Contribution of oxidative stress and impaired biogenesis of pancreatic β-cells to type 2 diabetes. Antioxid Redox Signal  2019; 31(10): 722-51.
 [http://dx.doi.org/10.1089/ars.2018.7656] [PMID:  30450940]

[104]
Benáková Š, Holendová B, Plecitá-Hlavatá L. Redox homeostasis in pancreatic β-cells: From development to failure. Antioxidants  2021; 10(4): 526.
 [http://dx.doi.org/10.3390/antiox10040526] [PMID:  33801681]

[105]
Bilekova S, Sachs S, Lickert H. Pharmacological targeting of endoplasmic reticulum stress in pancreatic beta cells. Trends Pharmacol Sci  2021; 42(2): 85-95.
 [http://dx.doi.org/10.1016/j.tips.2020.11.011] [PMID:  33353789]

[106]
Zhang J, An H, Ni K, et al. Glutathione prevents chronic oscillating glucose intake-induced β-cell dedifferentiation and failure. Cell Death Dis  2019; 10(4): 321.
 [http://dx.doi.org/10.1038/s41419-019-1552-y] [PMID:  30975975]

[107]
Kitamura YI, Kitamura T, Kruse JP, et al. FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction. Cell Metab  2005; 2(3): 153-63.
 [http://dx.doi.org/10.1016/j.cmet.2005.08.004] [PMID:  16154098]

[108]
Dumayne C, Tarussio D, Sanchez-Archidona AR, et al. Klf6 protects β-cells against insulin resistance-induced dedifferentiation. Mol Metab  2020; 35: 100958.
 [http://dx.doi.org/10.1016/j.molmet.2020.02.001] [PMID:  32244185]

[109]
Mak TCS, Ohlen YV, Wang YF, et al. β-cell dedifferentiation is associated with epithelial-mesenchymal transition triggered by miR-7-mediated repression of mSwi/Snf complex. bioRxiv  2019; 789461.
 [http://dx.doi.org/10.1101/789461]

[110]
de Jesus DS, Mak TCS, Wang Y-F, et al. Dysregulation of the Pdx1/Ovol2/Zeb2 axis in dedifferentiated β-cells triggers the induction of genes associated with epithelial-mesenchymal transition in diabetes. Mol Metab  2021; 53: 101248.
 [http://dx.doi.org/10.1016/j.molmet.2021.101248] [PMID:  33989778]

[111]
Ibrahim S, Johnson M, Stephens CH, et al. β-Cell pre-mir-21 induces dysfunction and loss of cellular identity by targeting transforming growth factor beta 2 (Tgfb2) and Smad family member 2 (Smad2) mRNAs. Mol Metab  2021; 53: 101289.
 [http://dx.doi.org/10.1016/j.molmet.2021.101289] [PMID:  34246804]

[112]
Gallo R, Gambelli F, Gava B, et al. Generation and expansion of multipotent mesenchymal progenitor cells from cultured human pancreatic islets. Cell Death Differ  2007; 14(11): 1860-71.
 [http://dx.doi.org/10.1038/sj.cdd.4402199] [PMID:  17612586]

[113]
Eberhardt M, Salmon P, von Mach M-A, et al. Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun  2006; 345(3): 1167-76.
 [http://dx.doi.org/10.1016/j.bbrc.2006.05.016] [PMID:  16713999]

[114]
Huang H, Tang X. Phenotypic determination and characterization of nestin-positive precursors derived from human fetal pancreas. Lab Invest  2003; 83(4): 539-47.
 [http://dx.doi.org/10.1097/01.LAB.0000062890.40534.1C] [PMID:  12695557]

[115]
Abraham EJ, Leech CA, Lin JC, Zulewski H, Habener JF. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology  2002; 143(8): 3152-61.
 [http://dx.doi.org/10.1210/endo.143.8.8973] [PMID:  12130581]

[116]
Russ HA, Bar Y, Ravassard P, Efrat S. In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes  2008; 57(6): 1575-83.
 [http://dx.doi.org/10.2337/db07-1283] [PMID:  18316362]

[117]
Russ HA, Ravassard P, Kerr-Conte J, Pattou F, Efrat S. Epithelial-mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells. PLoS One  2009; 4(7): e6417.
 [http://dx.doi.org/10.1371/journal.pone.0006417] [PMID:  19641613]

[118]
Limbert C, Ebert R, Schilling T, et al. Functional signature of human islet-derived precursor cells compared to bone marrow-derived mesenchymal stem cells. Stem Cells Dev  2010; 19(5): 679-91.
 [http://dx.doi.org/10.1089/scd.2009.0241] [PMID:  19895235]

[119]
Russ HA, Sintov E, Anker-Kitai L, et al. Insulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitro. PLoS One  2011; 6(9): e25566.
 [http://dx.doi.org/10.1371/journal.pone.0025566] [PMID:  21984932]

[120]
Friedman-Mazursky O, Elkon R, Efrat S. Redifferentiation of expanded human islet β cells by inhibition of ARX. Sci Rep  2016; 6(1): 20698.
 [http://dx.doi.org/10.1038/srep20698] [PMID:  26856418]

[121]
Nathan G, Kredo-Russo S, Geiger T, et al. MiR-375 promotes redifferentiation of adult human β cells expanded in vitro. PLoS One  2015; 10(4): e0122108.
 [http://dx.doi.org/10.1371/journal.pone.0122108] [PMID:  25875172]

[122]
Wang Z, York NW, Nichols CG, Remedi MS. Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab  2014; 19(5): 872-82.
 [http://dx.doi.org/10.1016/j.cmet.2014.03.010] [PMID:  24746806]

[123]
Seeberger KL, Eshpeter A, Rajotte RV, Korbutt GS. Epithelial cells within the human pancreas do not coexpress mesenchymal antigens: Epithelial-mesenchymal transition is an artifact of cell culture. Lab Invest  2009; 89(2): 110-21.
 [http://dx.doi.org/10.1038/labinvest.2008.122] [PMID:  19079324]

[124]
Sheng C, Li F, Lin Z, et al. Reversibility of β-cell-specific transcript factors expression by long-term caloric restriction in db/db Mouse. J Diabetes Res  2016; 2016: 6035046.
 [http://dx.doi.org/10.1155/2016/6035046] [PMID:  26998492]

[125]
Csóka B, Törő G, Vindeirinho J, et al. A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity. FASEB J  2017; 31(11): 4985-97.
 [http://dx.doi.org/10.1096/fj.201700398R] [PMID:  28765173]

[126]
Latreille M, Hausser J, Stützer I, et al. MicroRNA-7a regulates pancreatic β cell function. J Clin Invest  2014; 124(6): 2722-35.
 [http://dx.doi.org/10.1172/JCI73066] [PMID:  24789908]

[127]
Fiori JL, Shin YK, Kim W, et al. Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet. Diabetes  2013; 62(10): 3500-13.
 [http://dx.doi.org/10.2337/db13-0266] [PMID:  23884882]

[128]
Belongie KJ, Ferrannini E, Johnson K, Andrade-Gordon P, Hansen MK, Petrie JR. Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk. PLoS One  2017; 12(8): e0182932.
 [http://dx.doi.org/10.1371/journal.pone.0182932] [PMID:  28846711]

[129]
Valdez IA, Dirice E, Gupta MK, Shirakawa J, Teo AKK, Kulkarni RN. Proinflammatory cytokines induce endocrine differentiation in pancreatic ductal cells via stat3-dependent NGN3 activation. Cell Rep  2016; 15(3): 460-70.
 [http://dx.doi.org/10.1016/j.celrep.2016.03.036] [PMID:  27068459]

[130]
Corritore E, Dugnani E, Pasquale V, et al. β-Cell differentiation of human pancreatic duct-derived cells after in vitro expansion. Cell Reprogram  2014; 16(6): 456-66.
 [http://dx.doi.org/10.1089/cell.2014.0025] [PMID:  25437872]

[131]
Lima MJ, Muir KR, Docherty HM, et al. Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells. Diabetes  2013; 62(8): 2821-33.
 [http://dx.doi.org/10.2337/db12-1256] [PMID:  23610058]

[132]
Lee H, Lee YS, Harenda Q, et al. Beta cell dedifferentiation induced by IRE1α deletion prevents type 1 diabetes. Cell Metab  2020; 31(4): 822-836.e5.
 [http://dx.doi.org/10.1016/j.cmet.2020.03.002] [PMID:  32220307]

[133]
Weir GC, Aguayo-Mazzucato C, Bonner-Weir S. β-cell dedifferentiation  in diabetes is important, but what is it? Islets  2013; 5(5): 233-7.
 [http://dx.doi.org/10.4161/isl.27494] [PMID:  24356710]

[134]
Zhu Y, Sun Y, Zhou Y, et al. MicroRNA-24 promotes pancreatic beta cells toward dedifferentiation to avoid endoplasmic reticulum stress-induced apoptosis. J Mol Cell Biol  2019; 11(9): 747-60.
 [http://dx.doi.org/10.1093/jmcb/mjz004] [PMID:  30753517]

[135]
Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF. Human β-cell proliferation and intracellular signaling: Driving in the dark without a road map. Diabetes  2012; 61(9): 2205-13.
 [http://dx.doi.org/10.2337/db12-0018] [PMID:  22751699]

[136]
Puddu A, Sanguineti R, Mach F, Dallegri F, Viviani GL, Montecucco F. Update on the protective molecular pathways improving pancreatic beta-cell dysfunction. Mediators Inflamm  2013; 2013: 750540.
 [http://dx.doi.org/10.1155/2013/750540] [PMID:  23737653]

[137]
Jiang W-J, Peng Y-C, Yang K-M. Cellular signaling pathways regulating β-cell proliferation as a promising therapeutic target in the treatment of diabetes. Exp Ther Med  2018; 16(4): 3275-85.
 [http://dx.doi.org/10.3892/etm.2018.6603] [PMID:  30233674]

[138]
Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal  2014; 7(344): re8.
 [http://dx.doi.org/10.1126/scisignal.2005189] [PMID:  25249658]

[139]
Bosco D, Rouiller DG, Halban PA. Differential expression of E-cadherin at the surface of rat β-cells as a marker of functional heterogeneity. J Endocrinol  2007; 194(1): 21-9.
 [http://dx.doi.org/10.1677/JOE-06-0169] [PMID:  17592017]

[140]
Rogers GJ, Hodgkin MN, Squires PE. E-cadherin and cell adhesion: A role in architecture and function in the pancreatic islet. Cell Physiol Biochem  2007; 20(6): 987-94.
 [http://dx.doi.org/10.1159/000110459] [PMID:  17982281]

[141]
Banerjee M, Virtanen I, Palgi J, Korsgren O, Otonkoski T. Proliferation and plasticity of human beta cells on physiologically occurring laminin isoforms. Mol Cell Endocrinol  2012; 355(1): 78-86.
 [http://dx.doi.org/10.1016/j.mce.2012.01.020] [PMID:  22314207]

[142]
Xu J, Lamouille S, Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell Res  2009; 19(2): 156-72.
 [http://dx.doi.org/10.1038/cr.2009.5] [PMID:  19153598]

[143]
Kim BN, Ahn DH, Kang N, et al. TGF-β-induced EMT and stemness characteristics are associated with epigenetic regulation in lung can-cer. Sci Rep  2020; 10(1): 10597.
 [http://dx.doi.org/10.1038/s41598-020-67325-7] [PMID:  32606331]

[144]
Lee J-H, Lee J-H, Rane SG. TGF-β signaling in pancreatic islet β cell development and function. Endocrinology  2021; 162(3): bqaa233.

[145]
Dhawan S, Dirice E, Kulkarni RN, Bhushan A. Inhibition of TGF-β signaling promotes human pancreatic β-cell replication. Diabetes  2016; 65(5): 1208-18.
 [http://dx.doi.org/10.2337/db15-1331] [PMID:  26936960]

[146]
Blum B, Roose AN, Barrandon O, et al. Reversal of β cell dedifferentiation by a small molecule inhibitor of the TGFβ pathway. eLife  2014; 3: e02809.
 [http://dx.doi.org/10.7554/eLife.02809] [PMID:  25233132]

[147]
Bertolino P, Holmberg R, Reissmann E, Andersson O, Berggren PO, Ibáñez CF. Activin B receptor ALK7 is a negative regulator of pancre-atic β-cell function. Proc Natl Acad Sci USA  2008; 105(20): 7246-51.
 [http://dx.doi.org/10.1073/pnas.0801285105] [PMID:  18480258]

[148]
Smart NG, Apelqvist AA, Gu X, et al. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol  2006; 4(2): e39.
 [http://dx.doi.org/10.1371/journal.pbio.0040039] [PMID:  16435884]

[149]
Brown ML, Schneyer AL. Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis. Trends Endocrinol Metab  2010; 21(7): 441-8.
 [http://dx.doi.org/10.1016/j.tem.2010.02.008] [PMID:  20382030]

[150]
Toren-Haritan G, Efrat S. TGFβ pathway inhibition redifferentiates human pancreatic islet β cells expanded in vitro. PLoS One  2015; 10(9): e0139168.
 [http://dx.doi.org/10.1371/journal.pone.0139168] [PMID:  26418361]

[151]
El-Gohary Y, Tulachan S, Guo P, et al. Smad signaling pathways regulate pancreatic endocrine development. Dev Biol  2013; 378(2): 83-93.
 [http://dx.doi.org/10.1016/j.ydbio.2013.04.003] [PMID:  23603491]

[152]
Xiao X, Gaffar I, Guo P, et al. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci USA  2014; 111(13): E1211-20.
 [http://dx.doi.org/10.1073/pnas.1321347111] [PMID:  24639504]

[153]
Lee J-H, Mellado-Gil JM, Bahn YJ, Pathy SM, Zhang YE, Rane SG. Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling. Cell Death Dis  2020; 11(3): 184.
 [http://dx.doi.org/10.1038/s41419-020-2365-8] [PMID:  32170115]

[154]
Shrestha N, Liu T, Ji Y, et al. Sel1L-Hrd1 ER-associated degradation maintains β cell identity via TGF-β signaling. J Clin Invest  2020; 130(7): 3499-510.
 [http://dx.doi.org/10.1172/JCI134874] [PMID:  32182217]

[155]
Kang Y, Ling J, Suzuki R, et al. SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium. PLoS One  2014; 9(9): e107948.
 [http://dx.doi.org/10.1371/journal.pone.0107948] [PMID:  25264609]

[156]
Rulifson IC, Karnik SK, Heiser PW, et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA  2007; 104(15): 6247-52.
 [http://dx.doi.org/10.1073/pnas.0701509104] [PMID:  17404238]

[157]
Liu Z, Habener JF. Wnt signaling in pancreatic islets. Adv Exp Med Biol  2010; 654: 391-419.
 [http://dx.doi.org/10.1007/978-90-481-3271-3_17] [PMID:  20217507]

[158]
Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J  2012; 31(12): 2714-36.
 [http://dx.doi.org/10.1038/emboj.2012.150] [PMID:  22617422]

[159]
Loh C-Y, Chai JY, Tang TF, et al. The e-cadherin and n-cadherin switch in epithelial-to-mesenchymal transition: Signaling, therapeutic implications, and challenges. Cells  2019; 8(10): 1118.
 [http://dx.doi.org/10.3390/cells8101118] [PMID:  31547193]

[160]
Basu S, Cheriyamundath S, Ben-Ze’ev A. Cell-cell adhesion: Linking
Wnt/β-catenin signaling with partial EMT and stemness traits
in tumorigenesis. F1000Res 2018; 7: F1000 Faculty Rev-1488. 

[161]
Ikonomou L, Geras-Raaka E, Raaka BM, Gershengorn MC. Beta-catenin signalling in mesenchymal islet-derived precursor cells. Cell Prolif  2008; 41(3): 474-91.
 [http://dx.doi.org/10.1111/j.1365-2184.2008.00527.x] [PMID:  18422699]

[162]
Lenz A, Toren-Haritan G, Efrat S. Redifferentiation of adult human β cells expanded in vitro by inhibition of the WNT pathway. PLoS One  2014; 9(11): e112914.
 [http://dx.doi.org/10.1371/journal.pone.0112914] [PMID:  25393025]

[163]
Jazurek-Ciesiolka M, Janikiewicz J, Dobrzyn P, Dziewulska A, Kozinski K, Dobrzyn A. Oleic acid increases the transcriptional activity of FoxO1 by promoting its nuclear translocation and β-catenin binding in pancreatic β-cells. Biochim Biophys Acta Mol Basis Dis  2019; 1865(10): 2753-64.
 [http://dx.doi.org/10.1016/j.bbadis.2019.06.018] [PMID:  31255704]

[164]
Bar Y, Russ HA, Knoller S, Ouziel-Yahalom L, Efrat S. HES-1 is involved in adaptation of adult human beta-cells to proliferation in vitro. Diabetes  2008; 57(9): 2413-20.
 [http://dx.doi.org/10.2337/db07-1323] [PMID:  18599525]

[165]
Bar Y, Russ HA, Sintov E, Anker-Kitai L, Knoller S, Efrat S. Redifferentiation of expanded human pancreatic β-cell-derived cells by inhibition of the NOTCH pathway. J Biol Chem  2012; 287(21): 17269-80.
 [http://dx.doi.org/10.1074/jbc.M111.319152] [PMID:  22457355]

[166]
Voutsadakis IA. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer. Tumour Biol  2012; 33(4): 897-910.
 [http://dx.doi.org/10.1007/s13277-012-0355-x] [PMID:  22399444]

[167]
Díaz VM, Viñas-Castells R, García de Herreros A. Regulation of the protein stability of EMT transcription factors. Cell Adhes Migr  2014; 8(4): 418-28.
 [http://dx.doi.org/10.4161/19336918.2014.969998] [PMID:  25482633]

[168]
Banno A, Garcia DA, van Baarsel ED, et al. Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition. Oncotarget  2016; 7(16): 21527-41.
 [http://dx.doi.org/10.18632/oncotarget.7596] [PMID:  26930717]

[169]
Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature  2003; 426(6968): 895-9.
 [http://dx.doi.org/10.1038/nature02263] [PMID:  14685250]

[170]
Le Guerroué F, Youle RJ. Ubiquitin signaling in neurodegenerative diseases: An autophagy and proteasome perspective. Cell Death Differ  2021; 28(2): 439-54.
 [http://dx.doi.org/10.1038/s41418-020-00667-x] [PMID:  33208890]

[171]
Sun-Wang JL, Yarritu-Gallego A, Ivanova S, Zorzano A. The ubiquitin-proteasome system and autophagy: Self-digestion for metabolic health. Trends Endocrinol Metab  2021; 32(8): 594-608.
 [http://dx.doi.org/10.1016/j.tem.2021.04.015] [PMID:  34034951]

[172]
Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. J Biol Chem  2003; 278(3): 1817-23.
 [http://dx.doi.org/10.1074/jbc.M208815200] [PMID:  12397066]

[173]
Nandi D, Tahiliani P, Kumar A, Chandu D. The ubiquitin-proteasome system. J Biosci  2006; 31(1): 137-55.
 [http://dx.doi.org/10.1007/BF02705243] [PMID:  16595883]

[174]
Varshavsky A. The early history of the ubiquitin field. Protein Sci  2006; 15(3): 647-54.
 [http://dx.doi.org/10.1110/ps.052012306] [PMID:  16501229]

[175]
Ventii KH, Wilkinson KD. Protein partners of deubiquitinating enzymes. Biochem J  2008; 414(2): 161-75.
 [http://dx.doi.org/10.1042/BJ20080798] [PMID:  18687060]

[176]
Voutsadakis IA. The ubiquitin-proteasome system and signal transduction pathways regulating epithelial mesenchymal transition of cancer. J Biomed Sci  2012; 19(1): 67.
 [http://dx.doi.org/10.1186/1423-0127-19-67] [PMID:  22827778]

[177]
Tsubakihara Y, Moustakas A. Epithelial-mesenchymal transition and metastasis under the control of transforming growth factor β. Int J Mol Sci  2018; 19(11): 3672.
 [http://dx.doi.org/10.3390/ijms19113672] [PMID:  30463358]

[178]
Claiborn KC, Sachdeva MM, Cannon CE, Groff DN, Singer JD, Stoffers DA. Pcif1 modulates Pdx1 protein stability and pancreatic β cell function and survival in mice. J Clin Invest  2010; 120(10): 3713-21.
 [http://dx.doi.org/10.1172/JCI40440] [PMID:  20811152]

[179]
Sancho R, Gruber R, Gu G, Behrens A. Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ, and β cells. Cell Stem Cell  2014; 15(2): 139-53.
 [http://dx.doi.org/10.1016/j.stem.2014.06.019] [PMID:  25105579]

[180]
Itoh M, Kim C-H, Palardy G, et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell  2003; 4(1): 67-82.
 [http://dx.doi.org/10.1016/S1534-5807(02)00409-4] [PMID:  12530964]

[181]
Horn S, Kobberup S, Jørgensen MC, et al. Mind bomb 1 is required for pancreatic β-cell formation. Proc Natl Acad Sci USA  2012; 109(19): 7356-61.
 [http://dx.doi.org/10.1073/pnas.1203605109] [PMID:  22529374]

[182]
Han SI, Aramata S, Yasuda K, Kataoka K. MafA stability in pancreatic β cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3. Mol Cell Biol  2007; 27(19): 6593-605.
 [http://dx.doi.org/10.1128/MCB.01573-06] [PMID:  17682063]

[183]
Malenczyk K, Szodorai E, Schnell R, et al. Secretagogin protects Pdx1 from proteasomal degradation to control a transcriptional program required for β cell specification. Mol Metab  2018; 14: 108-20.
 [http://dx.doi.org/10.1016/j.molmet.2018.05.019] [PMID:  29910119]

[184]
Kitiphongspattana K, Mathews CE, Leiter EH, Gaskins HR. Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic β-cells. J Biol Chem  2005; 280(16): 15727-34.
 [http://dx.doi.org/10.1074/jbc.M410876200] [PMID:  15705591]

[185]
Yan F-F, Lin C-W, Cartier EA, Shyng SL. Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of β-cell ATP-sensitive potassium channels. Am J Physiol Cell Physiol  2005; 289(5): C1351-9.
 [http://dx.doi.org/10.1152/ajpcell.00240.2005] [PMID:  15987767]

[186]
Kawaguchi M, Minami K, Nagashima K, Seino S. Essential role of ubiquitin-proteasome system in normal regulation of insulin secretion. J Biol Chem  2006; 281(19): 13015-20.
 [http://dx.doi.org/10.1074/jbc.M601228200] [PMID:  16543239]

[187]
Gorrepati KDD, Lupse B, Annamalai K, Yuan T, Maedler K, Ardestani A. Loss of deubiquitinase USP1 blocks pancreatic β-cell apoptosis by inhibiting DNA damage response. iScience  2018; 1: 72-86.
 [http://dx.doi.org/10.1016/j.isci.2018.02.003] [PMID:  30227958]

[188]
Yamagata K, Nammo T, Moriwaki M, et al. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes  2002; 51(1): 114-23.
 [http://dx.doi.org/10.2337/diabetes.51.1.114] [PMID:  11756330]

[189]
Kim MH, Rebbert ML, Ro H, Won M, Dawid IB. Cell adhesion in zebrafish embryos is modulated by March 8. PLoS One  2014; 9(4): e94873.
 [http://dx.doi.org/10.1371/journal.pone.0094873] [PMID:  24752240]

[190]
Zhu J, Deng S, Duan J, et al. FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma. Oncol Lett  2014; 7(6): 2185-91.
 [http://dx.doi.org/10.3892/ol.2014.2031] [PMID:  24932313]

[191]
Shrestha H, Ryu T, Seo YW, et al. Hakai, an E3-ligase for E-cadherin, stabilizes δ-catenin through Src kinase. Cell Signal  2017; 31: 135-45.
 [http://dx.doi.org/10.1016/j.cellsig.2017.01.009] [PMID:  28069439]

[192]
Niño CA, Sala S, Polo S. When ubiquitin meets E-cadherin: Plasticity of the epithelial cellular barrier. Semin Cell Dev Biol  2019; 93: 136-44.
 [http://dx.doi.org/10.1016/j.semcdb.2018.12.005] [PMID:  30566893]

[193]
Tang L, Yi X-M, Chen J, et al. Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells. Oncotarget  2016; 7(13): 15738-46.
 [http://dx.doi.org/10.18632/oncotarget.7393] [PMID:  26894856]

[194]
Jeon YK, Kim CK, Hwang KR, et al. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination. Cell Death Differ  2017; 24(3): 469-80.
 [http://dx.doi.org/10.1038/cdd.2016.143] [PMID:  28009353]

[195]
Yan L, Lin M, Pan S, Assaraf YG, Wang ZW, Zhu X. Emerging roles of F-box proteins in cancer drug resistance. Drug Resist Updat  2020; 49: 100673.
 [http://dx.doi.org/10.1016/j.drup.2019.100673] [PMID:  31877405]

[196]
Shi J, Liu Y, Xu X, et al. Deubiquitinase USP47/UBP64E regulates β-catenin ubiquitination and degradation and plays a positive role in Wnt signaling. Mol Cell Biol  2015; 35(19): 3301-11.
 [http://dx.doi.org/10.1128/MCB.00373-15] [PMID:  26169834]

[197]
Cai J, Culley MK, Zhao Y, Zhao J. The role of ubiquitination and deubiquitination in the regulation of cell junctions. Protein Cell  2018; 9(9): 754-69.
 [http://dx.doi.org/10.1007/s13238-017-0486-3] [PMID:  29080116]

[198]
Lin Y, Wang Y, Shi Q, et al. Stabilization of the transcription factors slug and twist by the deubiquitinase dub3 is a key requirement for tumor metastasis. Oncotarget  2017; 8(43): 75127-40.
 [http://dx.doi.org/10.18632/oncotarget.20561] [PMID:  29088851]

[199]
Filios SR, Xu G, Chen J, Hong K, Jing G, Shalev A. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 pro-tein signaling and beta cell apoptosis. J Biol Chem  2014; 289(52): 36275-83.
 [http://dx.doi.org/10.1074/jbc.M114.592360] [PMID:  25391656]

[200]
Joglekar MV, Patil D, Joglekar VM, et al. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets  2009; 1(2): 137-47.
 [http://dx.doi.org/10.4161/isl.1.2.9578] [PMID:  21099261]

[201]
Beattie GM, Rubin JS, Mally MI, Otonkoski T, Hayek A. Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes  1996; 45(9): 1223-8.
 [http://dx.doi.org/10.2337/diab.45.9.1223] [PMID:  8772726]

[202]
Beattie GM, Itkin-Ansari P, Cirulli V, et al. Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes  1999; 48(5): 1013-9.
 [http://dx.doi.org/10.2337/diabetes.48.5.1013] [PMID:  10331405]

[203]
Bar-Nur O, Gerli MFM, Di Stefano B, et al. Direct reprogramming of mouse fibroblasts into functional skeletal muscle progenitors. Stem Cell Reports  2018; 10(5): 1505-21.
 [http://dx.doi.org/10.1016/j.stemcr.2018.04.009] [PMID:  29742392]

[204]
Sintov E, Nathan G, Knoller S, Pasmanik-Chor M, Russ HA, Efrat S. Inhibition of ZEB1 expression induces redifferentiation of adult human β cells expanded in vitro. Sci Rep  2015; 5(1): 13024.
 [http://dx.doi.org/10.1038/srep13024] [PMID:  26264186]
Rights & Permissions Print Cite
Article Metrics
1
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1573399818666220519143414	Print ISSN 1573-3998
Publisher Name Bentham Science Publisher	Online ISSN 1875-6417
Current Diabetes Reviews

Advancement in Understanding the Concept of Epithelial to Mesenchymal Transition in Pancreatic β-Cells: Implication in Diabetes

Abstract Play Pause

Related Journals

Related Books

Abstract
